Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Background The interest in elite athletes’ mental health has increased over the past decade. However, there is still a ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Generative artificial intelligence tools are becoming more available, and, for some workers, indispensable for their jobs.

and care in presenting medical information.” Weir highlighted that AI is turbo-boosting data visualisation, accelerating creativity and enhancing interactivity by generating alternative formats ...

And where in all this was the state’s medical board, the regulatory entity ... professional practice — the point of licensing is to give professionals a say in who gets to keep their license.